Canada
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
40.42%
|
Jan. 28, 2024 | USD 414.20 | -1.65% |
|
Canada |
|
2 |
22.27%
|
Dec. 31, 2023 | USD 52.50 | 1.95% |
|
Canada |
|
3 |
15.05%
|
March 31, 2024 | USD 2.65 | -1.93% |
|
Canada |
|
4 |
13.29%
|
Dec. 31, 2023 | USD 125.74 | -0.23% |
|
Canada |
|
5 |
12.42%
|
Dec. 31, 2023 | USD 9.51 | -0.80% |
|
Canada |
|
6 |
11.25%
|
Dec. 31, 2023 | USD 49.82 | 0.09% |
|
Canada |
|
7 |
10.61%
|
Feb. 29, 2024 | USD 47.70 | -1.25% |
|
Canada |
|
8 |
10.10%
|
March 31, 2024 | USD 10.66 | 0.87% |
|
Canada |
|
9 |
8.96%
|
Dec. 31, 2023 | USD 167.01 | -0.85% |
|
Canada |
|
10 |
8.86%
|
Dec. 31, 2023 | USD 23.12 | -1.32% |
|
Canada |
|
11 |
7.19%
|
Jan. 31, 2024 | USD 1.82 | -0.24% |
|
Canada |
|
12 |
4.07%
|
Dec. 31, 2023 | USD 7.37 | 1.49% |
|
Canada |
|
13 |
1.51%
|
March 30, 2024 | USD 1.77 | 4.73% |
|
Canada |
|
14 |
0.99%
|
Dec. 31, 2023 | USD 17.67 | 0.98% |
|
Canada |
|
15 |
-1.14%
|
Dec. 31, 2023 | USD 4.00 | 3.39% |
|
Canada |
|
16 |
-2.11%
|
Dec. 31, 2023 | USD 6.09 | -0.88% |
|
Canada |
|
17 |
-10.25%
|
Sept. 30, 2024 | USD 1.06 | 0.14% |
|
Canada |
|
18 |
-10.45%
|
Dec. 31, 2023 | USD 2.96 | 1.10% |
|
Canada |
|
19 |
-34.35%
|
March 31, 2024 | USD 2.55 | 24.33% |
|
Canada |
|
20 |
-323.63%
|
Dec. 31, 2023 | USD 5.03 | 6.19% |
|
Canada |
The Eyewear company in Canada with the highest Return on Capital Employed (ROCE) is Lululemon Athletica Inc. (NasdaqGS: LULU) at 40.42%.
The Eyewear company in Canada with the lowest Return on Capital Employed (ROCE) is POET Technologies Inc. (TSXV: PTK.V) at -323.63%.
The top 10 Eyewear companies in Canada by Return on Capital Employed (ROCE) are Lululemon Athletica Inc., Gildan Activewear Inc., Medexus Pharmaceuticals Inc., Loblaw Companies Limited, Cipher Pharmaceuticals Inc., CCL Industries Inc., Aritzia Inc., Canada Goose Holdings Inc., Boyd Group Services Inc. and Jamieson Wellness Inc..
The bottom 10 Eyewear companies in Canada by Return on Capital Employed (ROCE) are POET Technologies Inc., Canopy Growth Corporation, HLS Therapeutics Inc., Unisync Corp., Kits Eyecare Ltd., Knight Therapeutics Inc., Bausch + Lomb Corporation, Birks Group Inc., Bausch Health Companies Inc. and Reitmans (Canada) Limited.